- Home
- PKBK vs LYEL Comparison
PKBK vs LYEL Comparison
Compare PKBK & LYEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PKBK
- LYEL
- Stock Information
- Founded
- PKBK 1999
- LYEL 2018
- Country
- PKBK United States
- LYEL United States
- Employees
- PKBK N/A
- LYEL N/A
- Industry
- PKBK Major Banks
- LYEL Biotechnology: Pharmaceutical Preparations
- Sector
- PKBK Finance
- LYEL Health Care
- Exchange
- PKBK Nasdaq
- LYEL Nasdaq
- Market Cap
- PKBK 223.5M
- LYEL 207.7M
- IPO Year
- PKBK N/A
- LYEL 2021
- Fundamental
- Price
- PKBK $19.63
- LYEL $0.40
- Analyst Decision
- PKBK
- LYEL Sell
- Analyst Count
- PKBK 0
- LYEL 2
- Target Price
- PKBK N/A
- LYEL $1.00
- AVG Volume (30 Days)
- PKBK 22.9K
- LYEL 648.7K
- Earning Date
- PKBK 04-17-2025
- LYEL 05-20-2025
- Dividend Yield
- PKBK 3.66%
- LYEL N/A
- EPS Growth
- PKBK 24.29
- LYEL N/A
- EPS
- PKBK 2.41
- LYEL N/A
- Revenue
- PKBK $64,206,999.00
- LYEL $61,000.00
- Revenue This Year
- PKBK N/A
- LYEL N/A
- Revenue Next Year
- PKBK N/A
- LYEL N/A
- P/E Ratio
- PKBK $8.17
- LYEL N/A
- Revenue Growth
- PKBK N/A
- LYEL N/A
- 52 Week Low
- PKBK $15.24
- LYEL $0.39
- 52 Week High
- PKBK $24.29
- LYEL $2.88
- Technical
- Relative Strength Index (RSI)
- PKBK 63.01
- LYEL 37.66
- Support Level
- PKBK $18.97
- LYEL $0.41
- Resistance Level
- PKBK $19.94
- LYEL $0.51
- Average True Range (ATR)
- PKBK 0.49
- LYEL 0.05
- MACD
- PKBK 0.13
- LYEL 0.00
- Stochastic Oscillator
- PKBK 84.26
- LYEL 8.33
About PKBK Parke Bancorp Inc.
Parke Bancorp Inc operates as a commercial bank providing personal and financial services to individuals and small to mid-sized businesses in various states of the USA. The bank offers services such as loan products, deposit services, and other financial products through its retail branches and other channels to its customers. Its lending businesses are commercial real estate lending, residential real estate lending, and construction lending among others. The Company operates one reportable segment of business, community banking.
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.